International Edition
Latest News
Health

Neonatal MR1T Cells Have Diverse TCR Usage, Study Finds

Human neonatal MR1T cells emerge from the thymus at birth with diverse T-cell receptor usage, but they remain less cytotoxic and cannot respond to many common childhood pathogens, according to a study published on Mar 18, 2025 in…

Human neonatal MR1T cells emerge from the thymus at birth with diverse T-cell receptor usage, but they remain less cytotoxic and cannot respond to many common childhood pathogens, according to a study published on Mar 18, 2025 in bioRxiv.

The research, titled “Human Neonatal MR1T Cells Have Diverse TCR Usage, are Less Cytotoxic and are Unable to Respond to Many Common Childhood Pathogens,” was conducted by authors including Dylan Kain, Deborah Lewinsohn, David Lewinsohn, and Benjamin Bimber from Oregon Health and Science University in Portland, Oregon, alongside Jamie Rossjohn and Wael Awad from Monash University in Melbourne, Victoria, Australia, and other researchers.

To examine the differences, the study enrolled healthy adult participants and expectant mothers from the Portland area after obtaining consent. Adult participants donated blood to collect peripheral blood mononuclear cells, while umbilical cord blood samples were collected from expectant mothers at delivery to obtain cord blood mononuclear cells.

Researchers sorted the cells for MR1/5-OP-RU-tetramer positive MR1-restricted T cells and obtained single-cell gene expression and single-cell TCR-sequencing using the 10X genomics platform.

According to the study details available through dbGaP study phs003810.v1.p1, the major goals were to compare gene expression and TCR usage between adult and cord blood samples to understand how the cells develop after birth.

The findings showed that while MR1T cells emerge from the thymus at birth with some effector functions, they expand in the periphery and continue to mature after birth, indicating they are influenced by different life exposures.

Adult participants in the research met specific criteria: no known health conditions, ages 18 to 65 years, not taking immunosuppressive drugs, and negative testing for HIV and Mycobacterium tuberculosis infection. Expectant mothers had term deliveries with no reported health problems from the baby.

The research team acknowledged participants who gave time and dedication to the health research, as well as Erin Merrifield of the Department of Pediatrics at OHSU and Dr. Marielle Gold for their contributions.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”